Vycor Medical, Inc.
VYCO
$0.068
$0.00324.94%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -193.50K | -185.60K | -107.20K | -69.70K | -93.10K |
| Total Depreciation and Amortization | 62.10K | 61.60K | 61.00K | 60.80K | 61.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.20K | 12.30K | 15.40K | 10.90K | 10.80K |
| Change in Net Operating Assets | 220.90K | 190.00K | 37.20K | 27.30K | 11.90K |
| Cash from Operations | 103.90K | 78.50K | 6.70K | 29.40K | -9.50K |
| Capital Expenditure | -10.30K | -9.40K | -9.40K | -9.40K | -3.20K |
| Sale of Property, Plant, and Equipment | 0.00 | 200.00 | 500.00 | 100.00 | 100.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.20K | -9.20K | -8.90K | -9.30K | -3.10K |
| Total Debt Issued | 112.50K | 114.60K | 116.30K | 116.30K | 165.20K |
| Total Debt Repaid | -117.60K | -118.10K | -118.00K | -116.10K | -116.10K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.10K | -3.50K | -1.70K | 200.00 | 49.10K |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.50K | 65.90K | -3.90K | 20.30K | 36.60K |
